Gilead Presents Data Demonstrating Established, Investigational HIV Drugs
Drug Topics
MARCH 15, 2025
Among the drugs presented, Biktarvy and lenacapavir, teropavimab, and zinlirvimab (LTZ) demonstrate rates of suppression of HIV, and vesatolimod is well tolerated.
Let's personalize your content